Literature DB >> 6651372

1 Alpha 2 alpha 3 alpha collagen is arthritogenic.

K Morgan, H B Evans, S A Firth, M N Smith, S Ayad, J B Weiss, P J Lennox Holt.   

Abstract

Native 1 alpha 2 alpha 3 alpha collagen (500 micrograms per rat) was both immunogenic and arthritogenic in Alderley Park rats (46% developed arthritis) but only immunogenic in Sprague-Dawley rats. Conversely, native type II collagen (500 micrograms per rat) was immunogenic and arthritogenic in both strains (64% arthritic in Alderley Park strain, 57% arthritic in Sprague-Dawley strain). The inflammatory polyarthritis induced by 1 alpha 2 alpha 3 alpha collagen was similar to that produced by native type II collagen in clinical appearance, time of onset, and histology. Antibodies raised to native bovine type II collagen cross-reacted with native 1 alpha 2 alpha 3 alpha collagen and vice versa. Thus the minor collagen component of cartilage, the 1 alpha 2 alpha 3 alpha collagen, as well as the major collagen component, type II collagen, are immunogenic and arthritogenic in the rat, with strain differences.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6651372      PMCID: PMC1001329          DOI: 10.1136/ard.42.6.680

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

1.  A modified uronic acid carbazole reaction.

Authors:  T BITTER; H M MUIR
Journal:  Anal Biochem       Date:  1962-10       Impact factor: 3.365

2.  Collagen heterogeneity in human cartilage: identification of several new collagen chains.

Authors:  R E Burgeson; D W Hollister
Journal:  Biochem Biophys Res Commun       Date:  1979-04-27       Impact factor: 3.575

3.  Solid-phase radioimmunoassay for the detection of antibodies to collagen.

Authors:  R B Clague; R A Brown; J B Weiss; P J Holt
Journal:  J Immunol Methods       Date:  1979-05-10       Impact factor: 2.303

4.  Characterisation of another short-chain disulphide-bonded collagen from cartilage, vitreous and intervertebral disc.

Authors:  S Ayad; M Z Abedin; J B Weiss; S M Grundy
Journal:  FEBS Lett       Date:  1982-03-22       Impact factor: 4.124

5.  Isolation and characterisation of an unusual collagen from hyaline cartilage and intervertebral disc.

Authors:  S Ayad; M Z Abedin; S M Grundy; J B Weiss
Journal:  FEBS Lett       Date:  1981-01-26       Impact factor: 4.124

6.  Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats.

Authors:  M M Griffiths; E J Eichwald; J H Martin; C B Smith; C W DeWitt
Journal:  Arthritis Rheum       Date:  1981-06

7.  Immunisation against heterologous type II collagen induces arthritis in mice.

Authors:  J S Courtenay; M J Dallman; A D Dayan; A Martin; B Mosedale
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

8.  Native type II collagen-induced arthritis in the rat. I. Incidence and humoral response to collagen.

Authors:  K Morgan; R B Clague; M J Shaw; P J Holt
Journal:  Ann Rheum Dis       Date:  1980-06       Impact factor: 19.103

9.  Collagen-induced arthritis in rats. Evaluation of early immunologic events.

Authors:  J M Stuart; M A Cremer; A H Kang; A S Townes
Journal:  Arthritis Rheum       Date:  1979-12

10.  Autoimmunity to type II collagen an experimental model of arthritis.

Authors:  D E Trentham; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

  10 in total
  15 in total

Review 1.  Role of superantigens in experimental arthritis.

Authors:  A Abdelnour; Y X Zhao; T Bremell; R Holmdahl; A Tarkowski
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Identification of rat susceptibility loci for adjuvant-oil-induced arthritis.

Authors:  J C Lorentzen; A Glaser; L Jacobsson; J Galli; H Fakhrai-rad; L Klareskog; H Luthman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 3.  Experimental animal models resembling rheumatoid arthritis.

Authors:  P M Kaklamanis
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

4.  Antibodies to type II and XI collagens: evidence for the formation of antigen specific as well as cross reacting antibodies in patients with rheumatoid arthritis.

Authors:  K Morgan; C Buckee; I Collins; S Ayad; R B Clague; P J Holt
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

5.  Adjuvant-induced arthritis in rats. Evidence that autoimmunity to homologous collagens types I, II, IX and XI is not involved in the pathogenesis of arthritis.

Authors:  M A Cremer; A S Townes; A H Kang
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

6.  Experimental immune mediated arthritis in rhesus monkeys. A model for human rheumatoid arthritis?

Authors:  N P Bakker; M G van Erck; C Zurcher; P Faaber; A Lemmens; M Hazenberg; R E Bontrop; M Jonker
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

7.  Humoral immune response against minor collagens type IX and XI in patients with cartilage graft resorption after reconstructive surgery.

Authors:  J Bujia; S Alsalameh; A Naumann; E Wilmes; M Sittinger; G R Burmester
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

8.  Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats.

Authors:  S Carlsén; A S Hansson; H Olsson; D Heinegård; R Holmdahl
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

9.  Identification of an immunodominant B-cell epitope in bovine type II collagen and the production of antibodies to type II collagen by immunization with a synthetic peptide representing this epitope.

Authors:  K Morgan; S L Turner; I Reynolds; A H Hajeer; A Brass; J Worthington
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

10.  Incidence of antibodies to native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis.

Authors:  K Morgan; R B Clague; I Collins; S Ayad; S D Phinn; P J Holt
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.